Maria C. Di Paolo - Publications

Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future.

Journal: Medical sciences (Basel, Switzerland)

Published: June 22, 2026

Generative AI versus evidence-based resources in clinical decision-making by gastroenterology residents: an AIGO experiment.

Journal: Minerva gastroenterology

Published: May 20, 2026

Lactobacillus rhamnosus GG Administration Is Associated with Stimulation of Vitamin D/VDR Pathway and Mucosal Microbiota Modulation in Ulcerative Colitis Patients: A Pilot Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 22, 2025

Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study.

Journal: International journal of colorectal disease

Published: June 28, 2025

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Journal: Intestinal research

Published: April 29, 2025

Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 08, 2025

Non-Adherence Rate to Oral Mesalamine in Ulcerative Colitis Patients: A Systematic Review with Meta-Analysis.

Journal: Journal of personalized medicine

Published: February 11, 2025

Adherence to clinical and endoscopic standards of quality in inflammatory bowel disease: a nationwide survey from the Italian Association of Hospital Gastroenterologists and Endoscopists.

Journal: European journal of gastroenterology & hepatology

Published: January 25, 2025

Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Journal: Journal of clinical medicine

Published: September 23, 2024

Obesity and Weight Loss Diets in Inflammatory Bowel Disease Patients: What Physicians Should Know.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: April 25, 2024

Stenosing Crohn's disease patients display gut autophagy/oxidative stress imbalance.

Journal: Scientific reports

Published: April 15, 2024

Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.

Journal: Expert opinion on pharmacotherapy

Published: June 26, 2023